|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Healthy | |||||
| Blood Component Removal | |||||
| 2 | Interventions listed in this trial | ||||
| AMD3100 | |||||
| 3 | Additional drug interventions recognized in this trial | ||||
| JM 3100 | |||||
| 4 | More general drug interventions related to this trial | ||||
| Anti-HIV Agents | |||||
| Anti-Infective Agents | |||||
| Anti-Retroviral Agents | |||||
| Antiviral Agents | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| 5 | Sponsors listed in this trial | ||||
| National Heart, Lung, and Blood Institute (NHLBI) | |||||